{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:59:08Z","timestamp":1791327548535,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":2082,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1093\/annonc\/mdt592","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T05:23:58Z","timestamp":1390541038000},"page":"675-681","source":"Crossref","is-referenced-by-count":45,"title":["On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?"],"prefix":"10.1016","volume":"25","author":[{"given":"M.E.","family":"Hamaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Stauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"van Munster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt592_bb0010","unstructured":"seer.cancer.gov. 2013"},{"key":"10.1093\/annonc\/mdt592_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jgo.2012.08.003","article-title":"Cancer in the oldest old in the United Status: current statistics and projections","volume":"3","author":"Gundrum","year":"2012","journal-title":"J Geriatr Oncol"},{"issue":"27","key":"10.1093\/annonc\/mdt592_bb0020","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1093\/annonc\/mdt592_bb0025","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1093\/annonc\/mdt592_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"10.1093\/annonc\/mdt592_bb0035","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1200\/JCO.2003.08.091","article-title":"Are older French patients as willing as older American patients to undertake chemotherapy?","volume":"21","author":"Extermann","year":"2003","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1093\/annonc\/mdt592_bb0040","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/jnci\/86.23.1766","article-title":"Age and clinical decision making in oncology patients","volume":"86","author":"Yellen","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1093\/annonc\/mdt592_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejon.2003.12.010","article-title":"Older people with cancer: perceptions and feelings about information, decision-making and treatment\u2014a pilot study","volume":"8","author":"Chouliara","year":"2004","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"10.1093\/annonc\/mdt592_bb0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.6004\/jnccn.2012.0025","article-title":"Research priorities in geriatric oncology: addressing the needs of an aging population","volume":"10","author":"Hurria","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1093\/annonc\/mdt592_bb0055","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/annonc\/mdq687","article-title":"EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors","volume":"22","author":"Pallis","year":"2011","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdt592_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jgo.2010.03.005","article-title":"Geriatric Oncology Research in the Cooperative Groups: a report of a SIOG special meeting","volume":"1","author":"Hurria","year":"2010","journal-title":"J Geriatr Oncol"},{"issue":"18","key":"10.1093\/annonc\/mdt592_bb0065","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.ejca.2010.06.126","article-title":"Interconversion of three measures of performance status: an empirical analysis","volume":"46","author":"Ma","year":"2010","journal-title":"Eur J Cancer"},{"issue":"29","key":"10.1093\/annonc\/mdt592_bb0070","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1200\/JCO.2013.49.6125","article-title":"End points and trial design in geriatric oncology research: a Joint European Organisation for Research and Treatment of Cancer-Alliance for Clinical Trials in Oncology-International Society of Geriatric Oncology Position Article","volume":"31","author":"Wildiers","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1093\/annonc\/mdt592_bb0075","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/cncr.23968","article-title":"Cancer patient preferences for quality and length of life","volume":"113","author":"Meropol","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdt592_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00435382","article-title":"Choices in oncology: factors that influence patients' treatment preference","volume":"3","author":"Kiebert","year":"1994","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1093\/annonc\/mdt592_bb0085","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjc.6603662","article-title":"The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study","volume":"96","author":"Corner","year":"2007","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1093\/annonc\/mdt592_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2009.04.005","article-title":"Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: a qualitative study","volume":"74","author":"Puts","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1093\/annonc\/mdt592_bb0095","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1093\/annonc\/mdt592_bb0100","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1200\/JCO.2005.00.141","article-title":"Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials","volume":"23","author":"Townsley","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdt592_bb0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jgo.2012.03.002","article-title":"Clinical trial design in older adults with cancer: the need for new paradigms","volume":"3","author":"Lichtman","year":"2012","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdt592_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.2005.11.140","volume":"23","author":"Ardizzoni","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9779","key":"10.1093\/annonc\/mdt592_bb0115","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(11)60399-1","article-title":"Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial","volume":"377","author":"Seymour","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1093\/annonc\/mdt592_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.1989.7.1.36","article-title":"Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis","volume":"7","author":"Goldhirsch","year":"1989","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341934284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341934284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/3\/675\/350423\/mdt592.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:34:34Z","timestamp":1624520074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341934284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S092375341934284X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt592","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}